Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer's disease.
van Olst L, Simonton B, Edwards AJ, Forsyth AV, Boles J, Jamshidi P, Watson T, Shepard N, Krainc T, Argue BM, Zhang Z, Kuruvilla J, Camp L, Li M, Xu H, Norman JL, Cahan J, Vassar R, Chen J, Castellani RJ, Nicoll JA, Boche D, Gate D. van Olst L, et al. Among authors: kuruvilla j. Nat Med. 2025 May;31(5):1604-1616. doi: 10.1038/s41591-025-03574-1. Epub 2025 Mar 6. Nat Med. 2025. PMID: 40050704 Free PMC article.
Author Correction: Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer's disease.
van Olst L, Simonton B, Edwards AJ, Forsyth AV, Boles J, Jamshidi P, Watson T, Shepard N, Krainc T, Argue BM, Zhang Z, Kuruvilla J, Camp L, Li M, Xu H, Norman JL, Cahan J, Vassar R, Chen J, Castellani RJ, Nicoll JA, Boche D, Gate D. van Olst L, et al. Among authors: kuruvilla j. Nat Med. 2025 May;31(5):1712. doi: 10.1038/s41591-025-03664-0. Nat Med. 2025. PMID: 40155563 Free PMC article. No abstract available.
Fixed-Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis.
Bartlett NL, Sehn LH, Assouline S, Giri P, Kuruvilla J, Schuster SJ, Yoon SS, Fay K, Hess G, Dreyling M, Gutierrez NC, Cybulski E, Sabalvaro F, Penuel E, Teodoro V, Tracy S, Kuruvilla D, Chen J, Wiebking V, Wei MC, Budde LE. Bartlett NL, et al. Among authors: kuruvilla j. Am J Hematol. 2026 May;101(5):986-997. doi: 10.1002/ajh.70225. Epub 2026 Mar 20. Am J Hematol. 2026. PMID: 41862428 Free PMC article. Clinical Trial.
Management and Outcomes for Hodgkin's Lymphoma Patients with Partial Metabolic Response after First-Line Systemic Therapy.
Liao D, Aminilari M, Ye XY, Metser U, Singnurkar A, Bhella S, Crump M, Kridel R, Kukreti V, Kuruvilla J, Prica A, Vijenthira A, Cheung M, Rodin D, Tsao M, Hodgson D. Liao D, et al. Among authors: kuruvilla j. Pract Radiat Oncol. 2026 Feb 27:S1879-8500(26)00065-2. doi: 10.1016/j.prro.2026.01.017. Online ahead of print. Pract Radiat Oncol. 2026. PMID: 41765363 Free article.
302 results